Sotera Health (NASDAQ:SHC) Director Pincus & Co. Warburg Sells 9,720,000 Shares of Stock

Sotera Health Company (NASDAQ:SHC) Director Pincus & Co. Warburg sold 9,720,000 shares of the business’s stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total transaction of $158,727,600.00. Following the sale, the director owned 34,102,952 shares in the company, valued at $556,901,206.16. The trade was a 22.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Pincus & Co. Warburg also recently made the following trade(s):

• On Monday, November 10th, Pincus & Co. Warburg sold 18,000,000 shares of Sotera Health stock. The shares were sold at an average price of $15.65, for a total transaction of $281,700,000.00.

Sotera Health Stock Up 1.1%

Shares of NASDAQ SHC opened at $16.75 on Friday. The stock has a market capitalization of $4.76 billion, a price-to-earnings ratio of 88.16 and a beta of 1.81. Sotera Health Company has a 52 week low of $9.53 and a 52 week high of $17.78. The firm has a 50-day moving average price of $16.31 and a 200 day moving average price of $14.35. The company has a quick ratio of 2.18, a current ratio of 2.38 and a debt-to-equity ratio of 4.04.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. The company had revenue of $311.31 million during the quarter, compared to the consensus estimate of $303.63 million. Sotera Health had a net margin of 4.82% and a return on equity of 43.69%. Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. Equities research analysts anticipate that Sotera Health Company will post 0.61 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have weighed in on SHC shares. JPMorgan Chase & Co. upped their target price on Sotera Health from $14.00 to $16.00 and gave the company a “neutral” rating in a report on Wednesday, November 5th. BMO Capital Markets started coverage on Sotera Health in a research note on Thursday, November 13th. They set an “outperform” rating and a $19.00 price target on the stock. Wall Street Zen upgraded Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 16th. Piper Sandler lifted their target price on shares of Sotera Health from $15.00 to $17.00 and gave the company a “neutral” rating in a report on Wednesday, November 5th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Sotera Health in a research note on Tuesday. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $17.80.

Hedge Funds Weigh In On Sotera Health

Several hedge funds and other institutional investors have recently modified their holdings of the company. Charles Schwab Investment Management Inc. increased its holdings in shares of Sotera Health by 5.1% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,415,282 shares of the company’s stock worth $16,502,000 after acquiring an additional 68,087 shares during the period. Deutsche Bank AG raised its holdings in shares of Sotera Health by 1,902.2% during the first quarter. Deutsche Bank AG now owns 165,605 shares of the company’s stock valued at $1,931,000 after buying an additional 157,334 shares during the last quarter. Invesco Ltd. grew its position in Sotera Health by 10.4% in the 1st quarter. Invesco Ltd. now owns 306,398 shares of the company’s stock valued at $3,573,000 after buying an additional 28,892 shares in the last quarter. Nuveen LLC acquired a new stake in Sotera Health in the first quarter worth approximately $4,433,000. Finally, Caitong International Asset Management Co. Ltd lifted its position in Sotera Health by 3,690.1% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,691 shares of the company’s stock worth $31,000 after purchasing an additional 2,620 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.